Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/46030
Title: Psychological interventions for depression in children and young people with an intellectual disability and/or autism: Systematic review.
Authors: Cameron L.A.;Phillips K.;Melvin G.A.;Hastings R.P.;Gray K.M.
Monash Health Department(s): Psychology
Spiritual Care
Institution: (Cameron, Gray) Centre for Developmental Psychiatry and Psychology, Department of Psychiatry, School of Clinical Sciences at Monash Health, Monash University, Australia
(Phillips, Gray) Discipline of Paediatrics, School of Women?s and Children?s Health, University of New South Wales Medicine, The University of New South Wales, Australia
(Melvin) School of Psychology, Deakin University, Australia
(Hastings, Gray) Centre for Education, Appraisal and Research, University of Warwick, United Kingdom
Issue Date: 5-Sep-2021
Copyright year: 2021
Publisher: Cambridge University Press
Place of publication: United Kingdom
Publication information: British Journal of Psychiatry. 218(6) (pp 305-314), 2021. Date of Publication: June 2021.
Journal: British Journal of Psychiatry
Abstract: Background Children and young people with intellectual disability and/or Autism Spectrum Disorder (autism) experience higher rates of mental health problems, including depression, than their typically developing peers. Although international guidelines suggest psychological therapies as first-line intervention for children and young people, there is limited evidence for psychological therapy for depression in children and young people with intellectual disability and/or autism. Aims To evaluate the current evidence base for psychological interventions for depression in children and young people with intellectual disability and/or autism, and examine the experiences of children and young people with intellectual disability and/or autism, their families and therapists, in receiving and delivering psychological treatment for depression. Method Databases were searched up to 30 April 2020 using pre-defined search terms and criteria. Articles were independently screened and assessed for risk of bias. Data were synthesised and reported in a narrative review format. Results A total of 10 studies met the inclusion criteria. Four identified studies were clinical case reports and six were quasi-experimental or experimental studies. All studies were assessed as being of moderate or high risk of bias. Participants with intellectual disability were included in four studies. There was limited data on the experiences of young people, their families or therapists in receiving or delivering psychological treatment for depression. Conclusions Well-designed, randomised controlled trials are critical to develop an evidence base for psychological treatment for young people with intellectual disability and/or autism with depression. Future research should evaluate the treatment experiences of young people, their families and therapists.Copyright © The Author(s), 2020. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1192/bjp.2020.226
PubMed URL: 33198825 [http://www.ncbi.nlm.nih.gov/pubmed/?term=33198825]
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/46030
Type: Review
Subjects: adolescent
Asperger syndrome
autism
Beck Depression Inventory
cognitive behavioral therapy
depression/dt [Drug Therapy]
depression/th [Therapy]
disease association
drug substitution
drug withdrawal
dysthymia/th [Therapy]
Hamilton Depression Rating Scale
intellectual impairment
major depression/dt [Drug Therapy]
major depression/th [Therapy]
minor depression/th [Therapy]
pediatric patient
psychotherapy
role playing
treatment duration
treatment outcome
antidepressant agent/dt [Drug Therapy]
antidepressant agent/pv [Special Situation for Pharmacovigilance]
chlorpromazine/cb [Drug Combination]
chlorpromazine/dt [Drug Therapy]
chlorpromazine/pv [Special Situation for Pharmacovigilance]
fluoxetine/cb [Drug Combination]
fluoxetine/dt [Drug Therapy]
fluoxetine/pv [Special Situation for Pharmacovigilance]
olanzapine/cb [Drug Combination]
olanzapine/dt [Drug Therapy]
olanzapine/pv [Special Situation for Pharmacovigilance]
psychotropic agent/dt [Drug Therapy]
psychotropic agent/pv [Special Situation for Pharmacovigilance]
Type of Clinical Study or Trial: Systematic review and/or meta-analysis
Appears in Collections:Articles

Show full item record

Page view(s)

8
checked on Nov 24, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.